Kintara Therapeutics Inc
NASDAQ:KTRA 3:58:16 PM EDT
| Market Cap (Intraday) | 6.73M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.15 |
| 50-Day MA | $4.12 |
| 200-Day MA | $4.62 |
Kintara Therapeutics Inc Stock, NASDAQ:KTRA
9920 Pacific Heights Boulevard, Suite 150, San Diego, California 92121
United States of America
Phone: +1.858.350.4364
Number of Employees: 17
Description
Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.